Related references
Note: Only part of the references are listed.Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Daniel R. Scoles et al.
NATURE (2017)
Polyglutamine spinocerebellar ataxias - from genes to potential treatments
Henry L. Paulson et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Serum neurofilament light is sensitive to active cerebral small vessel disease
Thomas Gattringer et al.
NEUROLOGY (2017)
Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia
Ilaria Giordano et al.
NEUROLOGY (2017)
Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
Oskar Hansson et al.
NEUROLOGY (2017)
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
Lodewijk J. A. Toonen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Comparison of Different Symptom Assessment Scales for Multiple System Atrophy
Masaaki Matsushima et al.
CEREBELLUM (2016)
Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
Megan S. Keiser et al.
HUMAN MOLECULAR GENETICS (2016)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
Carlo Wilke et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration
Henrik Zetterberg
NEURON (2016)
Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis
Wataru Sako et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Tobias Skillback et al.
NEUROLOGY (2014)
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6 A 2-year follow-up study
H. Jacobi et al.
NEUROLOGY (2011)
Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2009)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia
W. F. Abdo et al.
NEUROLOGY (2006)
Scale for the assessment and rating of ataxia -: Development of a new clinical scale
T. Schmitz-Huebsch et al.
NEUROLOGY (2006)
Share Paper
